Large Germline Deletions of Mitochondrial Complex II Subunits SDHB and SDHD in Hereditary Paraganglioma
The DOI matches its Crossref record; 16 of the 17 references it cites were found in a registry or an index.
Abstract
More than 30% of adrenal pheochromocytomas are hereditary. These neuroendocrine tumors are major components of three inherited cancer syndromes: multiple endocrine neoplasia type 2, von Hippel-Lindau disease (VHL), and pheochromocytoma/paraganglioma syndrome (PC/PGL). Germline mutations in RET; VHL; and SDHB, SDHC, and SDHD are associated with multiple endocrine neoplasia type 2, VHL, and PC/PGL, respectively. The majority (>70%) of hereditary extraadrenal PCs [catecholamine-secreting paragangliomas (PGL)] are accounted for by germline intragenic mutations in SDHB, SDHC, or SDHD. Therefore, a subset of hereditary PGL is not accounted for. Here we report two unrelated hereditary PGL families, one with a germline whole-gene deletion of SDHD (family 4194), the other a partial deletion of SDHB (family BRZ01). Although they were initially designated mutation negative for all of the PC-associated genes after PCR-based analysis, we suspected that a large deletion or rearrangement might be present. Genotyping around the PC-associated genes demonstrated that both families were consistent with linkage with one of these genes. Using fine structure genotyping and semiquantitative duplex PCR analysis, we identified an approximately 96-kb deletion spanning SDHD in family 4194 and an approximately 1-kb deletion involving the 5' end of SDHB in family BRZ01. Thus, including SDHB and SDHD deletion analysis could increase gene-testing sensitivity for PGL patients, which would aid in genetic counseling and management of patients and families.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, mutations in subunit SdhB, SdhC, or SdhD are linked to tumorigenesis in the form of autosome-dominant familial paragangliomas and pheochromocytomas (1, 3, 16, 19, 33).”
From Loss of the SdhB, but Not the SdhA, Subunit of Complex II Triggers Reactive Oxygen Species-Dependent Hypoxia-Inducible Factor Activation and Tumorigenesis (2008) · cites this paper as [33]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene
Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F.-M., Orcutt, M. L., Stackhouse, T., Kuzmin, I., Modi, W., Geil, L., et al. (1993) · Science · doi:10.1126/science.8493574 · Cited by 2,973
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638 · cited 2×
“Indeed, the presence of only head and neck PGLs in this family with five affected relatives is consistent with SDHD involvement (1, 9). Furthermore, the single nonpenetrant case in this family (II-4) who inherited the SDHD deletion from his mother is consistent with maternal imprinting, a phenomenon that is well descr…”
BackgroundGerm-Line Mutations in Nonsyndromic Pheochromocytoma
Neumann, H. P. H., Bausch, B., McWhinney, S. R., Bender, B. U., Gimm, O., Franke, G., Schipper, J., Klisch, J., Altehoefer, C., Zerres, K., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020152 · Cited by 1,367
Self-citationAstuti, D., Latif, F., Dallol, A., Dahia, P. L. M., Douglas, F., George, E., Sköldberg, F., Husebye, E. S., Eng, C., & Maher, E. R. (2001) · The American Journal of Human Genetics · doi:10.1086/321282 · Cited by 1,087
Self-citationMutations in SDHC cause autosomal dominant paraganglioma, type 3
Niemann, S., & Müller, U. (2000) · Nature Genetics · doi:10.1038/81551 · Cited by 875
Eng, C. (1996) · JAMA · doi:10.1001/jama.1996.03540190047028 · Cited by 821
Self-citationA role for mitochondrial enzymes in inherited neoplasia and beyond
Eng, C., Kiuru, M., Fernandez, M. J., & Aaltonen, L. A. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1013 · Cited by 392
Self-citationVanharanta, S., Buchta, M., McWhinney, S. R., Virta, S. K., Peçzkowska, M., Morrison, C. D., Lehtonen, R., Januszewicz, A., Järvinen, H., Juhola, M., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/381054 · Cited by 389 · cited 1×
“SDHB intragenic mutations, however, have been associated with nontraditional histology renal cell carcinoma at very young ages ( 14 ).”
BackgroundSelf-citationBaysal, B. E., Willett-Brozick, J. E., Lawrence, E. C., Drovdlic, C. M., Savul, S. A., McLeod, D. R., Yee, H. A., Brackmann, D. E., Slattery, W. H., Myers, E. N., et al. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.3.178 · Cited by 339 · cited 2×
“SDHC account for up to 70% of familial head and neck PGL ( 8 ), perhaps 8% of apparently sporadic head and neck PGL (1) and approximately 9% of apparently sporadic PC (9).”
BackgroundHereditary paraganglioma targets diverse paraganglia: Table 1
Baysal, B. E. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.9.617 · Cited by 235 · cited 1×
“and SDHD have been reported, and all are intragenic mutations with no descriptions of large deletions or rearrangements (1, 3, 7, 12 ).”
Background
Cited by
Genetic Testing in Pheochromocytoma or Functional Paraganglioma
Amar, L., Bertherat, J., Baudin, E., Ajzenberg, C., Bressac-de Paillerets, B., Chabre, O., Chamontin, B., Delemer, B., Giraud, S., Murat, A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.1484 · Cited by 684
Mitochondrial tumour suppressors: a genetic and biochemical update
Gottlieb, E., & Tomlinson, I. P. M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1737 · Cited by 621
“Large germline deletions of SDHB , SDHC , SDHD and FH have also been reporte”
BackgroundPasini, B., McWhinney, S. R., Bei, T., Matyakhina, L., Stergiopoulos, S., Muchow, M., Boikos, S. A., Ferrando, B., Pacak, K., Assie, G., et al. (2008) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201904 · Cited by 487
Self-citationAmar, L., Baudin, E., Burnichon, N., Peyrard, S., Silvera, S., Bertherat, J., Bertagna, X., Schlumberger, M., Jeunemaitre, X., Gimenez-Roqueplo, A.-P., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0709 · Cited by 450
“QMPSF detected large deletions in SDHB in three patients, two with a deletion, including the first exon (28), and one with a deletion from exons 3–8 (Fig.”
BackgroundGuzy, R. D., Sharma, B., Bell, E., Chandel, N. S., & Schumacker, P. T. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01338-07 · Cited by 427
“However, mutations in subunit SdhB, SdhC, or SdhD are linked to tumorigenesis in the form of autosome-dominant familial paragangliomas and pheochromocytomas (1, 3, 16, 19, 33).”
BackgroundBardella, C., Pollard, P. J., & Tomlinson, I. (2011) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2011.07.003 · Cited by 395
Copy number variations and cancer
Shlien, A., & Malkin, D. (2009) · Genome Medicine · doi:10.1186/gm62 · Cited by 386
“[62]”
Ricketts, C. J., Forman, J. R., Rattenberry, E., Bradshaw, N., Lalloo, F., Izatt, L., Cole, T. R., Armstrong, R., Kumar, V. K. A., Morrison, P. J., et al. (2010) · Human Mutation · doi:10.1002/humu.21136 · Cited by 337
“Recently, germline SDHB/D deletions have been recognized as a significant cause of PCC/HNPGL susceptibility [McWhinney et al., 2004; Cascón et al., 2006; Amar et al., 2007].”
BackgroundBrouwers, F. M., Eisenhofer, G., Tao, J. J., Kant, J. A., Adams, K. T., Linehan, W. M., & Pacak, K. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0423 · Cited by 316
Timmers, H. J. L. M., Kozupa, A., Eisenhofer, G., Raygada, M., Adams, K. T., Solis, D., Lenders, J. W. M., & Pacak, K. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2315 · Cited by 276
“Apart from intragenic mutations, there are two reports on five patients with extraadrenal PGL related to large deletions of the SDHB gene (38, 39).”
BackgroundThe NGS in PPGL (NGSnPPGL) Study Group, Toledo, R. A., Burnichon, N., Cascon, A., Benn, D. E., Bayley, J.-P., Welander, J., Tops, C. M., Firth, H., Dwight, T., et al. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.185 · Cited by 275
Pasini, B., & Stratakis, C. A. (2009) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02111.x · Cited by 273
“…are occasionally found in affected carriers or their relatives such as papillary thyroid cancers [106, 127], adrenal neuroblastoma [65], pituitary adenoma [58, 93], bronchial carcinoid [94], ependymoma, melanoma, bone and soft tissue sarcoma [49], B-cell lymphoma [111] and colon cancer [58, 99].”
Ni, Y., Zbuk, K. M., Sadler, T., Patocs, A., Lobo, G., Edelman, E., Platzer, P., Orloff, M. S., Waite, K. A., & Eng, C. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.07.011 · Cited by 222
“In classic SDH-related pheochromocytoma/ paraganglioma syndromes, sometimes there is somatic loss of the remaining wild-type allele accompanying the germline mutation, but retention of the wild-type allele is also observed.(26,27) Even more puzzling is the well-documented maternally imprinted SDHD-related tumors.”
BackgroundSelf-citationNgeow, J., Mester, J., Rybicki, L. A., Ni, Y., Milas, M., & Eng, C. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1616 · Cited by 202
“The subset of patients who lacked germline PTEN pathogenic mutations, largedeletions,orVUSandwhohadelevatedperipheral manganese superoxide dismutase levels (15) were analyzed for SDHB–D mutations/variations as previously reported (29, 30).”
MethodSelf-citation15 YEARS OF PARAGANGLIOMA: Clinical manifestations of paraganglioma syndromes types 1–5
Benn, D. E., Robinson, B. G., & Clifton-Bligh, R. J. (2015) · Endocrine-Related Cancer · doi:10.1530/erc-15-0268 · Cited by 197
Neumann, H. P. H., Erlic, Z., Boedeker, C. C., Rybicki, L. A., Robledo, M., Hermsen, M., Schiavi, F., Falcioni, M., Kwok, P., Bauters, C., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4057 · Cited by 194
Self-citationClinical Predictors and Algorithm for the Genetic Diagnosis of Pheochromocytoma Patients
Erlic, Z., Rybicki, L., Peczkowska, M., Golcher, H., Kann, P. H., Brauckhoff, M., Müssig, K., Muresan, M., Schäffler, A., Reisch, N., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1237 · Cited by 175
Self-citationMatyakhina, L., Bei, T. A., McWhinney, S. R., Pasini, B., Cameron, S., Gunawan, B., Stergiopoulos, S. G., Boikos, S. A., Muchow, M., Dutra, A., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0797 · Cited by 152
Self-citationRichter, S., Peitzsch, M., Rapizzi, E., Lenders, J. W., Qin, N., de Cubas, A. A., Schiavi, F., Rao, J. U., Beuschlein, F., Quinkler, M., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2151 · Cited by 135
Germline copy number variation and cancer risk
Kuiper, R. P., Ligtenberg, M. J. L., Hoogerbrugge, N., & van Kessel, A. G. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.03.005 · Cited by 153
Clinical aspects of SDHx-related pheochromocytoma and paraganglioma
Timmers, H. J. L. M., Gimenez-Roqueplo, A.-P., Mannelli, M., & Pacak, K. (2009) · Endocrine-Related Cancer · doi:10.1677/erc-08-0284 · Cited by 131
“Apart from intragenic mutations, there are few reports on patients with PGLs relating to large deletions of the SDHB and SDHC gene ( McWhinney et al. 2004, Cascon et al. 2006).”
Ni, Y., He, X., Chen, J., Moline, J., Mester, J. L., Orloff, M. S., Ringel, M. D., & Eng, C. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr459 · Cited by 126
“Samples with melting curves that clustered differently from reference samples were directly sequenced for SDHB, SDHC or SDHD, as previously reported by our laboratory (40,41).”
ResultSelf-citationClinical and molecular progress in hereditary paraganglioma: Figure 1
Baysal, B. E. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2008.058560 · Cited by 86
Lung Cell Hypoxia: Role of Mitochondrial Reactive Oxygen Species Signaling in Triggering Responses
Schumacker, P. T. (2011) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201103-032mw · Cited by 95
Physiological consequences of complex II inhibition for aging, disease, and the mKATP channel
Wojtovich, A. P., Smith, C. O., Haynes, C. M., Nehrke, K. W., & Brookes, P. S. (2013) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2012.12.007 · Cited by 83
“Paraganglioma type 1 168000 [9,221,224,228–232]”
Paraganglioma, neuroblastoma, and a SDHB mutation: Resolution of a 30‐year‐old mystery
Schimke, R. N., Collins, D. L., & Stolle, C. A. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33384 · Cited by 84
“However, in some instances, the wild-type allele is retained [McWhinney et al., 2004].”
BackgroundCopy number variations and cancer susceptibility
Shlien, A., & Malkin, D. (2010) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328333dca4 · Cited by 77
RetractedMolecular characterisation of a common SDHB deletion in paraganglioma patients
Cascón, A., Landa, I., López-Jiménez, E. A., Díez-Hernández, A., Buchta, M., Montero‐Conde, C., Leskelä, S., Leandro-Garcia, L. J., Letón, R., Rodríguez‐Antona, C., et al. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2007.054965 · Cited by 82
Self-citationGross SDHB deletions in patients with paraganglioma detected by multiplex PCR: A possible hot spot?
Cascón, A., Montero‐Conde, C., Ruiz‐Llorente, S., Mercadillo, F., Letón, R., Rodríguez‐Antona, C., Martínez‐Delgado, B., Delgado, M., Díez, A., Rovira, A., et al. (2006) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20283 · Cited by 75
“The deletion of exon 1, which was found in two independent cases, matched the unique gross deletion previously reported by McWhinney et al. (2004), whereas deletion of the entire gene has not been reported before.”
BackgroundInfluentialMahdi, H., Mester, J. L., Nizialek, E. A., Ngeow, J. Y. Y., Michener, C. M., & Eng, C. (2014) · Cancer · doi:10.1002/cncr.29106 · Cited by 71
“67 Q2 55 (25) 4 (18) Q3 54 (23) 6 (27) Q4 56 (25) 4 (18)”
Self-citationIdentification of intragenic deletions and duplication in the FLCN gene in Birt‐Hogg‐Dubé syndrome
Benhammou, J. N., Vocke, C. D., Santani, A., Schmidt, L. S., Baba, M., Seyama, K., Wu, X., Korolevich, S., Nathanson, K. L., Stolle, C. A., et al. (2011) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20872 · Cited by 66
“, 2009), succinate dehydrogenase subunit B (SDHB[MIM185470]) (McWhinney et al., 2004), fumarate hydratase (FH[MIM136850]) (Ahvenainen et al.”
Blank, A., Schmitt, A. M., Korpershoek, E., van Nederveen, F., Rudolph, T., Weber, N., Strebel, R. T., de Krijger, R., Komminoth, P., & Perren, A. (2010) · Endocrine-Related Cancer · doi:10.1677/erc-09-0316 · Cited by 67
Baysal, B. E., & Maher, E. R. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0226 · Cited by 64
“A wide variety of intragenic mutations have been described and, more recently, single or multiple exon deletions (and, occasionally, intragenic duplications; McWhinney et al. 2004, Cascon et al. 2008, Neumann et al. 2009).”
BackgroundComprehensive Mutation Scanning of NF1 in Apparently Sporadic Cases of Pheochromocytoma
Bausch, B., Koschker, A., Faßnacht, M., Stoevesandt, J., Hoffmann, M. M., Eng, C., Allolio, B., & Neumann, H. P. H. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0780 · Cited by 58
Self-citationGenetic basis of phaeochromocytoma and paraganglioma
Benn, D. E., & Robinson, B. G. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.07.005 · Cited by 59
Berneburg, M., Kamenisch, Y., Krutmann, J., & Röcken, M. (2006) · Experimental Dermatology · doi:10.1111/j.1600-0625.2006.00508.x · Cited by 56
Penetrance and clinical consequences of a gross SDHB deletion in a large family
Solis, D. C., Burnichon, N., Timmers, H., Raygada, M. J., Kozupa, A., Merino, M. J., Makey, D., Adams, K. T., Vénisse, A., Gimenez‐Roqueplo, A., et al. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2009.01157.x · Cited by 57
“The first three families identified with this exon 1 mutation originated from Brazil, Portugal, and Spain (11, 12).”
BackgroundParaganglioma—All in the Family
Young, W. F., & Abboud, A. L. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2758 · Cited by 52
Simi, L., Sestini, R., Ferruzzi, P., Gaglianò, M. S., Gensini, F., Mascalchi, M., Guerrini, L., Pratesi, C., Pinzani, P., Nesi, G., et al. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.030353 · Cited by 51
Germline and somatic SDHx alterations in apparently sporadic differentiated thyroid cancer
Ni, Y., Seballos, S. S., Ganapathi, S. S., Gurin, D., Fletcher, B., Ngeow, J. Y. Y., Nagy, R. S., Kloos, R. T., Ringel, M. D., LaFramboise, T., et al. (2015) · Endocrine Related Cancer · doi:10.1530/erc-14-0537 · Cited by 43
“The samples with melting curves that clustered differently from reference samples were directly sequenced for SDHB, SDHC, or SDHD, as previously reported by our laboratory (Mutter et al. 2000, McWhinney et al. 2004).”
Self-citationCopy-number variants in patients with a strong family history of pancreatic cancer
Lucito, R., Suresh, S., Walter, K., Pandey, A., Lakshmi, B. V., Krasnitz, A., Sebat, J. L., Wigler, M. H., Klein, A. P., Brune, K. A., et al. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.10.4725 · Cited by 40
Candidate gene mutation analysis in bilateral adrenal pheochromocytoma and sympathetic paraganglioma
Korpershoek, E., Petri, B., van Nederveen, F. H., Dinjens, W. N. M., Verhofstad, A. A. J., de Herder, W. W., Schmid, S., Perren, A. A., Komminoth, P., & de Krijger, R. R. (2007) · Endocrine Related Cancer · doi:10.1677/erc-06-0044 · Cited by 37
“In addition, the technique used in our investigation cannot be used to detect all genetic changes in these candidate genes, i.e. it is not suitable for detecting large deletions, which have been demonstrated in VHL, SDHB, and SDHD (Maranchie et al. 2004, McWhinney et al. 2004, Cascon et al. 2005).”
MethodInfluentialThe first Dutch SDHB founder deletion in paraganglioma – pheochromocytoma patients
Bayley, J., Grimbergen, A., van Bunderen, P. A., van der Wielen, M. J. R., Kunst, H. P. M., Lenders, J. W. M., Jansen, J. C., Dullaart, R. P. F., Devilee, P., Corssmit, E. P. M., et al. (2009) · BMC Medical Genetics · doi:10.1186/1471-2350-10-34 · Cited by 40
“first described deletions of SDHB and SDHD in two families in 2004 [12].”
BackgroundRepair of mitochondrial DNA in aging and carcinogenesis
Berneburg, M., Kamenisch, Y., & Krutmann, J. (2005) · Photochemical & Photobiological Sciences · doi:10.1039/b507380d · Cited by 41
Perry, C. G., Young, W. F., McWhinney, S. R., Bei, T. A., Stergiopoulos, S. G., Knudson, R. A., Ketterling, R. P., Eng, C., Stratakis, C. A., & Carney, J. A. (2006) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000178087.69394.9f · Cited by 41
“PCR primers used for the KIT and SDHA, SDHB, SDHC, and SDHD analyses were described previously.(19,25)”
MethodSelf-citationReactive Oxygen Species and Oncoprotein Signaling-A Dangerous Liaison
Chong, S. J. F., Lai, J. X. H., Eu, J. Q., Bellot, G. L., & Pervaiz, S. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7441 · Cited by 30
“One example is the germline deletion of complex II subunit B (SdhB) in hereditary paraganglioma (214).”
Castellano, M., Mori, L., Giacchè, M., Agliozzo, E., Tosini, R., Panarotto, A., Cappelli, C., Mulatero, P., Cumetti, D., Veglio, F., et al. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1353.016 · Cited by 30
Genetic Testing in Pheochromocytoma‐ and Paraganglioma‐Associated Syndromes
Benn, D. E., Richardson, A. L., Marsh, D. J., & Robinson, B. G. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1353.011 · Cited by 36
The versatile biochemistry of iron in macrophage effector functions
Behmoaras, J. V. (2021) · FEBS Journal · doi:10.1111/febs.15682 · Cited by 32
The Occurrence of SDHB Gene Mutations in Pheochromocytoma
van Nederveen, F. H., Dinjens, W. N. M., Korpershoek, E., & de Krijger, R. R. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1353.018 · Cited by 26
Takahashi, M., Yang, X. J., McWhinney, S., Sano, N., Eng, C., Kagawa, S., Teh, B. T., & Kanayama, H.-O. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2005.031708 · Cited by 25
Self-citationThe pheochromocytoma and paraganglioma syndrome: Founder effects and the PGL 1 syndrome
Opocher, G., Boaretto, F., Pignataro, V., Demattè, S., Cecchini, M. E., Erlic, Z., & Schiavi, F. (2009) · Annales d Endocrinologie · doi:10.1016/j.ando.2009.02.007 · Cited by 19
Genetic Analysis of High Altitude Paragangliomas
Jech, M., Alvarado‐Cabrero, I., Albores‐Saavedra, J., Dahia, P. L. M., & Tischler, A. S. (2006) · Endocrine Pathology · doi:10.1385/ep:17:2:201 · Cited by 19
“We have not ruled out larger deletions of these two genes nor mutations of SDHC, which rarely can also predispose to the development of parasympathetic PGL [8, 11 ,12].”
BackgroundMontani, M., Schmitt, A. M., Schmid, S., Locher, T., Saremaslani, P., Heitz, P. U., Komminoth, P., & Perren, A. A. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.00996 · Cited by 17
“We cannot exclude large homozygous deletions or deletions encompassing single exons of the genes; however, at least in a familial setting, such alterations are reported to be rare (McWhinney et al. 2004).”
BackgroundBayley, J., Weiss, M. M., Grimbergen, A., van Brussel, B. T. J., Hes, F. J., Jansen, J. C., Verhoef, S., Devilee, P., Corssmit, E. P. M., & Vriends, A. H. J. T. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0084 · Cited by 19
“2004, McWhinney et al .”
Update on the Molecular Diagnosis of Endocrine Tumors: Toward –omics-Based Personalized Healthcare?
Weber, F., & Eng, C. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0212 · Cited by 16
“Over the subsequent few years, germline mutations in SDHB, SDHC, and SDHD, autosomal genes encoding three of the four subunits of mitochondrial complex II or succinyl dehydrogenase (SDH), were found in PC-PGL syndromes (50–54).”
BackgroundInfluentialSelf-citationDetermination of CYP2D6 gene copy number by multiplex polymerase chain reaction analysis
Leandro-Garcia, L. J., Leskelä, S., Montero‐Conde, C., Landa, I., López-Jiménez, E. A., Letón, R., Seeringer, A., Kirchheiner, J., Cascón, A., Robledo, M., et al. (2009) · Analytical Biochemistry · doi:10.1016/j.ab.2009.03.021 · Cited by 16
Familial Nonsyndromic Pheochromocytoma
Opocher, G., Schiavi, F., Iacobone, M., Toniato, A., Sattarova, S., Erlic, Z., Martella, M., Mian, C., Boschin, I. M., ZAMBONIN, L., et al. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1353.015 · Cited by 19
Familial pancreatic cancer: from genes to improved patient care
Hruban, R. H., Klein, A. P., Eshleman, J. R., Axilbund, J. E., & Goggins, M. (2007) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.1.1.81 · Cited by 19
Kodama, H., Iihara, M., Nissato, S., Isobe, K., Kawakami, Y., Okamoto, T., & Takekoshi, K. (2010) · Endocrine Journal · doi:10.1507/endocrj.k09e-324 · Cited by 14
“Given that only a small number of SDHB deletion cases have been described [10-18], it is difficult to meaningfully compare the phenotypes and penegest to us that these tests capable of detecting such large deletions, such as MLPA, should be made routine.”
BackgroundBennedbæk, M., Rossing, M., Rasmussen, Å. K., Gerdes, A., Skytte, A., Jensen, U. B., Nielsen, F. C., & Hansen, T. V. O. (2016) · Hereditary Cancer in Clinical Practice · doi:10.1186/s13053-016-0053-6 · Cited by 16
“This deletion has previously been reported in patients with PGL [21, 22].”
Manotas, M. C., Rivera-Herrera, A.-L., Gómez, A. M., Abisambra, P., Guevara, G., Medina, V., Tapiero, S., Huertas, A., Riaño-Moreno, J. C., Mejía, J. C., et al. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2022.999329 · Cited by 12
“38 years (13–47 years), which is comparable to what has been reported in the literature for carriers of this large deletion (8–30 years) (McWhinney et al., 2004).”
BackgroundGermline predisposition in multiple myeloma
Rodrigues, F. M., Jasielec, J. K., Perpich, M., Kim, A., Moma, L., Li, Y., Storrs, E. P., Wendl, M. C., Jayasinghe, R. G., Fiala, M. A., et al. (2024) · iScience · doi:10.1016/j.isci.2024.111620 · Cited by 12
Petenuci, J., Fagundes, G. F. C., Benedetti, A. F. F., Guimaraes, A. G., Afonso, A. C. F., Motta, F. T., Magalhães, A. L. F., Coura-Filho, G. B., Zerbini, M. C. N., Siqueira, S. A. C., et al. (2021) · Endocrine · doi:10.1007/s12020-020-02594-w · Cited by 13
Evidence for a Founder Effect of SDHB Exon 1 Deletion in Brazilian Patients With Paraganglioma
Fagundes, G. F. C., Freitas-Castro, F., de Santana, L. S., Afonso, A. C. F., Petenuci, J., Funari, M. F. A., Guimaraes, A. G., Ledesma, F. L., Pereira, M. A. A., Victor, C. R., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad028 · Cited by 13
Metastatic sympathetic paraganglioma in a patient with loss of the SDHC gene
Rich, T. A., Jackson, M., Román-Gonzaléz, A., Shah, K. B., Cote, G. J., & Jiménez, C. (2015) · Familial Cancer · doi:10.1007/s10689-015-9821-0 · Cited by 10
Novel SDHD germ‐line mutations in pheochromocytoma patients
Neumayer, C., Moritz, A., Asari, R., Weinhäusel, A., Hölzenbein, T., Kretschmer, G., Niederle, B., & Haas, O. A. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01822.x · Cited by 9
Hoekstra, A. S., van den Ende, B., Julià, X. P., van Breemen, L., Scheurwater, K., Tops, C. M. J., Malinoc, A., Devilee, P., Neumann, H. P. H., & Bayley, J.-P. (2016) · Clinical Genetics · doi:10.1111/cge.12843 · Cited by 10
Maher, E. R. (2006) · British Medical Bulletin · doi:10.1093/bmb/ldl002 · Cited by 9
Janecke, A., Willett-Brozick, J. E., Karas, C., Hasipek, M., Löffler‐Ragg, J., & Baysal, B. E. (2010) · Journal of Human Genetics · doi:10.1038/jhg.2009.142 · Cited by 8
Freitas-Castro, F., & Almeida, M. Q. (2024) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2024.101922 · Cited by 5
Novel germline SDHD deletion associated with an unusual sympathetic head and neck paraganglioma
Cadiñanos, J., Llorente, J. L., Rosa, J. D. L., Villameytide, J. A., Illán, R., Sánchez-Durán, N., Murías, E., & Cabanillas, R. (2010) · Head & Neck · doi:10.1002/hed.21384 · Cited by 4
“However, little is known regarding clinical features of patients carrying gross SDHD deletions, because only 1 study has reported such alterations to date.(17) We report a new germline SDHD deletion,”
BackgroundSDHC Methylation Pattern in Patients With Carney Triad
Daumová, M., Švajdler, M., Fabián, P., Křen, L., Babankova, I., Ježová, M., Šedivcová, M., Vaněček, T., Behenska, K., Michal, M., et al. (2021) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000920 · Cited by 4
Partial monosomy of 11q22.2q22.3 including the SDHD gene in individuals with developmental delay
Yelavarthi, K. K., Cabral, H., Wilson, G. N., Rohena, L. O., Risheg, H., Penton, A. L., Schleede, J. B., & Burnside, R. D. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36956 · Cited by 3
“While the vast majority of tumors are caused by intragenic mutations, one familywithhereditary extraadrenal paragangliomas of the head and neck was found to have a whole gene deletion of SDHD by quantitative RT-PCR [McWhinney et al., 2004].”
BackgroundMethodGene Dosage Analysis in a Clinical Environment: Gene-Targeted Microarrays as the Platform-of-Choice
Marquis‐Nicholson, R., Prosser, D. O., Love, J. M., & Love, D. R. (2013) · Microarrays · doi:10.3390/microarrays2020051 · Cited by 2
“Heterozygous deletion of exon 1 of the SDHB gene has been reported in several unrelated families with hereditary phaeochromocytoma [23,24].”
BackgroundSánchez, F. S. L., Lozano, M. N., Gorjón, P. S., Medina, A., Herrera, Á. M. M., & González‐Sarmiento, R. (2010) · Angiología · doi:10.1016/s0003-3170(10)70051-1 · Cited by 2
Malignant pheochromocytoma in the elderly: which is the best management in clinical practice?
Mazza, A., & Rubello, D. (2015) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000000386 · Cited by 3
Secondary Hypertension: Pheochromocytoma
Young, W. F. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-3053-9.50016-0 · Cited by 3
Paraganglioma and Pheochromocytoma
Iacobone, M., & Torresan, F. (2021) · Springer eBooks · doi:10.1007/978-3-030-62241-1_15 · Cited by 2
Molecular Biology of Pheochromocytomas and Paragangliomas
King, E. E., & Dahia, P. L. M. (2009) · Springer eBooks · doi:10.1007/978-1-4419-1069-1_13 · Cited by 2
“In addition, it has been reported that some cases of pheochromocytoma/paraganglioma are characterized genetically by large deletions or chromosomal rearrangements rather than typical point mutations [ 72 ].”
BackgroundTimmers, H. J. L. M., & Pacák, K. (2007) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2.3.399 · Cited by 1
The Pathogenesis of Pheochromocytomas: Of Mice and Men
Korpershoek, E. (2011) · EUR Research Repository (Erasmus University Rotterdam) · Cited by 1
Loureiro, V. C. (2007) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2007.tde-22042007-204736
Timmers, H. J. L. M., Gimenez‐Roqueplo, A., Mannelli, M., & Pacák, K. (2009)
Neumann, H. P. H., Michelsen, K. S., & Yu, R. (2014)
Timmers, H. J. L. M., Kozupa, A., Eisenhofer, G., Raygada, M. J., Adams, K. T., Solis, D. C., Lenders, J. W. M., & Pacák, K. (2007)
Paraganglioma and Pheochromocytoma
Sandberg, A. A. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-510-7_5
(2007) · Wiley eBooks · doi:10.1002/9780470692196.refs
Metadata
- Authors
- McWhinney, S. R., Pilarski, R. T., Forrester, S. R., Schneider, M. C., Sarquis, M. M., Dias, E. P., & Eng, C.
- Affiliations
- Clinical Cancer Genetics Program (S.R.M., R.T.P., C.E.), Columbus, Ohio 43210;
- The Ohio State University (US)
- SIU Medicine (US)
- Human Cancer Genetics Program (S.R.M., R.T.P., M.M.S., C.E.), Columbus, Ohio 43210;
- Universidade Federal de Minas Gerais (BR)
- University of Cambridge (GB)
- Corresponding author
- Eng, Charis
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2004-11-01
- Volume
- 89
- Issue
- 11
- Pages
- 5694-5699
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2169562930
- Cited by
- 89
- References
- 17
- Citations by year
- 2024: 2 · 2023: 2 · 2022: 1 · 2021: 3 · 2020: 1 · 2017: 1 · 2016: 3 · 2015: 6 · 2014: 3 · 2013: 2
- FWCI
- 10.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ohio State University
- Torbay Medical Research Fund
- U.S. Public Health Service
- National Cancer Institute (P-30-CA-16058, P30CA016058)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD039058, R01 HD39058)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Clinical Neurology › Neurofibromatosis and Schwannoma Cases
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- hereditary paraganglioma, germline deletion, SDHB, SDHD, succinate dehydrogenase, pheochromocytoma, multiple endocrine neoplasia type 2, von Hippel-Lindau disease, genetic counseling
- MeSH terms
- Adult, Female, Humans, Male, Paraganglioma, Succinate Dehydrogenase, Polymerase Chain Reaction, Gene Deletion, Germ-Line Mutation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.